×

Access Whitepaper

First Name
Last Name
Company
Thank you!
Error - something went wrong!
   

Assessing Cardiac Safety in Oncology Drug Development

Based on a Cardiac Safety Research Consortium Think Tank held in October 2017 on “Detection, Assessment, and Risk Mitigation of Cardiac Safety Signals in Oncology Drug Development, this article discusses emerging cardio-oncology nuances and the latest regulatory thinking on ways to manage risks. 

No Previous Flipbooks

Next Flipbook
Lack of Training Compromises Trial Results, Expert Says
Lack of Training Compromises Trial Results, Expert Says

At its very core, a clinical trial is a measurement system; yet, the industry has not focused enough on tra...

Request a Genetics in Clinical Trials training session

What You'll Learn